1000 related articles for article (PubMed ID: 24684285)
21. Thyroid cancer detection rate and associated risk factors in patients with thyroid nodules classified as Bethesda category III.
Mileva M; Stoilovska B; Jovanovska A; Ugrinska A; Petrushevska G; Kostadinova-Kunovska S; Miladinova D; Majstorov V
Radiol Oncol; 2018 Sep; 52(4):370-376. PubMed ID: 30265655
[TBL] [Abstract][Full Text] [Related]
22. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.
Gao LY; Wang Y; Jiang YX; Yang X; Liu RY; Xi XH; Zhu SL; Zhao RN; Lai XJ; Zhang XY; Zhang B
Medicine (Baltimore); 2017 Apr; 96(16):e6564. PubMed ID: 28422844
[TBL] [Abstract][Full Text] [Related]
24. Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.
Babajani A; Rahmani S; Raoufi M; Eidgahi ES; Dastjerdi AV; Behfarnia P; Khalili S; Moghaddam NA
Front Endocrinol (Lausanne); 2023; 14():1135196. PubMed ID: 37313444
[TBL] [Abstract][Full Text] [Related]
25. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
26. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
Kiernan CM; Solórzano CC
J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
28. Core-needle biopsy versus repeat fine-needle aspiration for thyroid nodules initially read as atypia/follicular lesion of undetermined significance.
Choi YJ; Baek JH; Suh CH; Shim WH; Jeong B; Kim JK; Song DE; Kim TY; Chung KW; Lee JH
Head Neck; 2017 Feb; 39(2):361-369. PubMed ID: 27704650
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of Thyroid Imaging Reporting and Data System in the prediction of malignancy in nodules with atypia and follicular lesion of undetermined significance cytologies.
Baser H; Cakir B; Topaloglu O; Alkan A; Polat SB; Dogan HT; Yazicioğlu MO; Aydin C; Ersoy R
Clin Endocrinol (Oxf); 2017 Apr; 86(4):584-590. PubMed ID: 27911001
[TBL] [Abstract][Full Text] [Related]
30. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
31. Subcategorization of Bethesda System Category III by Ultrasonography.
Lee S; Shin JH; Oh YL; Hahn SY
Thyroid; 2016 Jun; 26(6):836-42. PubMed ID: 27094511
[TBL] [Abstract][Full Text] [Related]
32. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy.
Kuru B; Atmaca A; Kefeli M
Diagn Cytopathol; 2016 May; 44(5):394-8. PubMed ID: 26917413
[TBL] [Abstract][Full Text] [Related]
33. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
34. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
Seagrove-Guffey MA; Hatic H; Peng H; Bates KC; Odugbesan AO
Cancer Cytopathol; 2018 Oct; 126(10):881-888. PubMed ID: 30335212
[TBL] [Abstract][Full Text] [Related]
35. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
[TBL] [Abstract][Full Text] [Related]
36. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Kim M; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Feb; 29(2):216-221. PubMed ID: 30421654
[TBL] [Abstract][Full Text] [Related]
37. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
[TBL] [Abstract][Full Text] [Related]
38. Significance of Subcategory Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Showing Both Cytologic and Architectural Atypia in Thyroid Aspiration Cytology.
Jung YY; Jung S; Lee HW; Oh YL
Acta Cytol; 2015; 59(5):370-6. PubMed ID: 26529329
[TBL] [Abstract][Full Text] [Related]
39. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients.
Arva NC; Deitch SG
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):753-60. PubMed ID: 25879311
[TBL] [Abstract][Full Text] [Related]
40. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]